| Stress UI | Urgency UI | ||||
|---|---|---|---|---|---|
| Intervention category | Mean Percent* (95% CI) | Forecast Percent† (95% CI) | Intervention category | Mean Percent* (95% CI) | Forecast Percent† (95% CI) |
| Pharmacological | Pharmacological | ||||
| BTX (B) | 42.8 (27.2, 60.0) | 42.8 (8.9, 85.1) | |||
| Anticholinergic (C) | 21.4 (12.8, 33.6) | 21.4 (3.5, 67.0) | |||
| Periurethral Bulking (U) | 16.9 (5.3, 42.4) | 16.9 (1.0, 80.2) | |||
| Alpha Agonist (A) | 15.8 (6.1, 35.3) | 15.8 (1.0, 77.4) | |||
| Anticholinergic + Hormones (C+H) | 1.7 (0.1, 21.7) | 1.7 (0.1, 21.7) | |||
| Hormones (H) | 1.7 (0.1, 21.7) | 1.7 (0.1, 21.7) | |||
| Nonpharmacological | Nonpharmacological | ||||
| Behavioral Therapy (T) | 46.4 (25.8, 68.3) | 46.4 (4.8, 93.7) | Behavioral Therapy (T) | 30.8 (16.7, 49.8) | 30.8 (5.3, 77.9) |
| Neuromodulation (N) | 34.9 (19.5, 54.4) | 34.9 (3.1, 90.0) | Neuromodulation (N) | 29.4 (16.6, 46.5) | 29.4 (5.1, 76.3) |
| Intravesical pressure release (V) | 29.2 (7.0, 69.3) | 29.2 (1.7, 91.0) | |||
| Neuromodulation + Behavioral Therapy (N+T) | 28.4 (8.7, 62.2) | 28.4 (1.8, 89.4) | |||
| Combination | Combination | ||||
| Hormones + Behavioral Therapy (H+T) | 63.7 (21.4, 91.9) | 63.7 (6.2, 97.9) | |||
| Anticholinergic + Behavioral Therapy (C+T) | 25.7 (13.2, 43.8) | 25.7 (4.1, 73.4) | |||
| No Treatment | No Treatment | ||||
| Placebo/Sham/No Treatment (P) | 13.3 (6.9, 24.2) | 13.3 (0.9, 71.7) | Placebo/Sham/No Treatment (P) | 13.2 (7.3, 22.7) | 13.2 (2.0, 53.3) |
The summary mean percentage (with confidence interval) of women in the trials receiving the intervention with the outcome.
The predicted percentage (with confidence interval) of women who receive the intervention in future trials, or in similar settings, who will have the outcome.
From: Appendix H, Results of Subgroup Analyses by Type of UI
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.